The economics of laparoscopic Nissen fundoplication

Clinical Gastroenterology and Hepatology

Volumn 1, Issue 4, 2003, Pages 328-332

  Dire, Christopher A ^a   Jones, Michael P ^b   Rulyak, Stephen J ^a   Kahrilast, Peter J ^b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIULCER AGENT; HISTAMINE H2 RECEPTOR ANTAGONIST; PROTON PUMP INHIBITOR; SPASMOLYTIC AGENT;

ADULT; COHORT ANALYSIS; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; ECONOMIC ASPECT; ENDOSCOPY; FEMALE; GASTROESOPHAGEAL REFLUX; HEALTH CARE COST; HEALTH CARE SYSTEM; HOSPITAL ADMISSION; HOSPITAL COST; HOSPITALIZATION; HUMAN; LAPAROSCOPIC SURGERY; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE COMPLICATION; REVIEW; STOMACH FUNDOPLICATION; SURGICAL TECHNIQUE;

EID: 0141955184     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1542-3565(03)00138-1     Document Type: Article

References (22)

1. Gallup Organization. Heartburn Across America: a Gallup Organization survey. Washington DC: Gallup Organization, 1988.
2. Locke GR 3rd, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ 3rd. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology 1997;112:1448-1456.
3. Dimenas E, Glise H, Hallerback B, Hernqvist H, Svedlund J, Wiklund I. Quality of life in patients with upper gastrointestinal symptoms. An improved evaluation of treatment regimens? Scand J Gastroenterol 1993;28:681-687.
4. Sandler RS, Everhart JE, Donowitz M, Adams E, Cronin K, Goodman C, Gemmen E, Shah S, Avdic A, Rubin R. The burden of selected digestive diseases in the United States. Gastroenterology 2002;122:1500-1511.
5. Hetzel DJ, Dent J, Reed WD, Narielvala FM, Mackinnon M, McCarthy JH, Mitchell B, Beveridge BR, Laurence BH, Gibson GG, Grant AK, Shearman DJC, Whitehead R, Buckle PJ. Healing and relapse of severe peptic esophagitis after treatment with omeprazole. Gastroenterology 1988;95:903-912.
6. Landreneau RJ, Wiechmann RJ, Hazelrigg SR, Santucci TS, Boley TM, Magee MJ, Naunheim KS. Success of laparoscopic fundoplication for gastroesophageal reflux disease. Ann Thorac Surg 1998;66:1886-1893.
7. Dallemagne B, Weerts JM, Jeahes C, Markiewicz S. Results of laparoscopic Nissen fundoplication. Hepatogastroenterology 1998;45:1338-1343.
8. Spechler SJ, Lee E, Ahnen D, Goyal RK, Hirano I, Ramirez F, Raufman JP, Sampliner R, Schnell T, Sontag S, Vlahcevic ZR, Young R, Williford W. Long-term outcome of medical and surgical therapies for gastroesophageal reflux disease: follow-up of a randomized controlled trial. JAMA 2001;285:2331-2338.
9. Lundell L, Miettinen P, Myrvold HE, Pedersen SA, Liedman B, Hatlebakk JG, Julkonen R, Levander K, Carlsson J, Lamm M, Wiklund I. Continued (5-year) follow up of a randomized clinical study comparing antireflux surgery and omeprazole in gastroesophageal reflux disease. J Am Coll Surg 2001;192:172-181.
10. Coelho JC, Wiederkehr JC, Campos AC, Andrigueto PC. Conversions and complications of laparoscopic treatment of gastroesophageal reflux disease. J Am Coll Surg 1999;189:356-361.
11. Van Den Boom G, Go PM, Hameeteman W, Dallemagne B, Ament AJ. Cost effectiveness of medical versus surgical treatment in patients with severe or refractory gastroesophageal reflux disease in the Netherlands. Scand J Gastroenterol 1996;31:1-9.
12. Heudebert GR, Marks R, Wilcox CM, Centor RM. Choice of long-term strategy for the management of patients with severe esophagitis: a cost-utility analysis. Gastroenterology 1997;112:1078-1086.
13. Holzman MD, Mitchel EF, Ray WA, Smalley WE. Use of healthcare resources among medically and surgically treated patients with gastroesophageal reflux disease: a population-based study. J Am Coll Surg 2001;192:17-24.
14. Heikkinen TJ, Haukipuro K, Koivukangas P, Sorasto A, Autio R, Sodervik H, Makela H, Hulkko A. Comparison of costs between laparoscopic and open Nissen fundoplication: a prospective randomized study with a 3-month follow up. J Am Coll Surg 1999;188:368-376.
15. Blomqvist AM, Lonroth H, Dalenback J, Lundell L. Laparoscopic or open fundoplication? A complete cost analysis. Surg Endosc 1998;12:1209-1212.
16. Rantanen TK, Salo JA, Sipponen JT. Fatal and life-threatening complications in antireflux surgery: analysis of 5,502 operations. Br J Surg 1999;86:1573-1577.
17. Kiviluoto T, Siren J, Farkkila M, Luukkonen P, Salo J, Kivilaakso E. Laparoscopic Nissen fundoplication: a prospective analysis of 200 consecutive patients. Surg Laparosc Endosc 1998;8:429-434.
18. Perdikis G, Hinder RA, Lund RJ, Raiser F, Katada N. Laparoscopic Nissen fundoplication: where do we stand? Surg Laparosc Endosc 1997;7:17-21.
19. Hinder RA, Libbey JS, Gorecki P, Bammer T. Antireflux surgery. Indications, preoperative evaluation, and outcome. Gastroenterol Clin North Am 1999;28:987-1005.
20. Jones MP, Kubik CM. Fundoplication does not cure gastroesophageal reflux disease. Am J Gastroenterol 1996;91:A1891.
21. DiRe CA, Billingsley KG, Todd-Stenberg JA, Dominitz JA. Continued use of acid suppressant medication following antireflux surgery. Gastroenterology 2002;122:A75.
22. Vakil N, Treml S. The outcome of laparoscopic fundoplication for reflux disease in community practice in the USA. Gastroenterology 2001;120:A16.